Back to Search
Start Over
YS Biopharma completes enrolment for PIKA Rabies Vaccine phase three clinical trial
- Source :
- M2 Pharma. November 1, 2023
- Publication Year :
- 2023
-
Abstract
- M2 PHARMA-November 1, 2023-YS Biopharma completes enrolment for PIKA Rabies Vaccine phase three clinical trial (C)2023 M2 COMMUNICATIONS YS Biopharma Co Ltd (NASDAQ: YS), a China-based global biopharmaceutical company, announced [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- M2 Pharma
- Publication Type :
- News
- Accession number :
- edsgcl.771042424